Tiong Cheng Yeo
← Back to National University Heart Centre Singapore
National University Heart Centre Singapore
Tiong Cheng Yeo works in Cardiac Valve Diseases and Treatments, Cardiovascular Function and Risk Factors, Aortic Disease and Treatment Approaches, Acute Myocardial Infarction Research, Coronary Interventions and Diagnostics. Recorded institutional associations include National University of Singapore, Nanyang Technological University, National University Heart Centre Singapore.
Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.
Selected research works
Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.
Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: a prospective cohort study
2019 · 911 citationsValue of a Doppler-Derived Index Combining Systolic and Diastolic Time Intervals in Predicting Outcome in Primary Pulmonary Hypertension
1998 · 547 citationsPrognostic value of a doppler index combining systolic and diastolic performance in idiopathic-dilated cardiomyopathy
1998 · 384 citationsClinical Profile and Outcome in 52 Patients with Cardiac Pseudoaneurysm
1998 · 291 citationsPrognostic Implications of Raphe in Bicuspid Aortic Valve Anatomy
2017 · 135 citationsImpact of left ventricular diastolic dysfunction on left atrial volume and function: a volumetric analysis
2009 · 99 citationsSex Differences in Phenotypes of Bicuspid Aortic Valve and Aortopathy
2017 · 99 citationsStatins for Primary Prevention of Cardiovascular Disease in Elderly Patients: Systematic Review and Meta-Analysis
2015 · 94 citationsThe burden of cardiovascular disease in Asia from 2025 to 2050: a forecast analysis for East Asia, South Asia, South-East Asia, Central Asia, and high-income Asia Pacific regions
2024 · 86 citationsMechanisms of hemolysis after mitral valve repair: assessment by serial echocardiography
1998 · 83 citationsThe ESC-EORP EURO-ENDO (European Infective Endocarditis) registry
2019 · 82 citationsLeft ventricular fluid dynamics in heart failure: echocardiographic measurement and utilities of vortex formation time
2011 · 75 citationsImpact of the COVID-19 Pandemic on Door-to-Balloon Time for Primary Percutaneous Coronary Intervention ― Results From the Singapore Western STEMI Network ―
2020 · 71 citationsInter-ethnic differences in valve morphology, valvular dysfunction, and aortopathy between Asian and European patients with bicuspid aortic valve
2017 · 69 citationsClinical characteristics and outcome in postinfarction pseudoaneurysm
1999 · 64 citationsImpact of coconut oil consumption on cardiovascular health: a systematic review and meta-analysis
2019 · 60 citationsInfective endocarditis in adult patients with congenital heart disease
2022 · 50 citationsPredictors of embolism and death in left-sided infective endocarditis: the European Society of Cardiology EURObservational Research Programme European Infective Endocarditis registry
2023 · 47 citationsFramingham Risk Score Inadequately Predicts Cardiac Risk in Young Patients Presenting with a First Myocardial Infarction
2010 · 37 citationsAssociation between smoking status and outcomes in myocardial infarction patients undergoing percutaneous coronary intervention
2021 · 37 citationsCharacteristics and outcomes of young patients with ST segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: retrospective analysis in a multiethnic Asian population
2021 · 36 citationsRecalibration of the Global Registry of Acute Coronary Events risk score in a multiethnic Asian population
2011 · 35 citationsSurgery and outcome of infective endocarditis in octogenarians: prospective data from the ESC EORP EURO-ENDO registry
2022 · 35 citationsEffects of Sodium/Glucose Cotransporter 2 (SGLT2) Inhibitors and Combined SGLT1/2 Inhibitors on Cardiovascular, Metabolic, Renal, and Safety Outcomes in Patients with Diabetes: A Network Meta-Analysis of 111 Randomized Controlled Trials
2022 · 34 citationsTrends and predictions of metabolic risk factors for acute myocardial infarction: findings from a multiethnic nationwide cohort
2023 · 34 citations
